S&P 500 Financials Sector SEC Filings — August 14, 2026

14-08-2026

T. Rowe Price OHA Select Private Credit Fund filed an 8-K on August 13, 2026, announcing its financial results and total distributions declared for the second quarter of 2026. The filing includes a press release as Exhibit 99.1. No specific financial figures or performance comparisons are provided in the 8-K itself, only the fact of the announcement.

• · The press release was issued on August 13, 2026.
• · The filing is under Item 8.01 (Other Events).
• · The registrant is an emerging growth company.

14-08-2026

T. Rowe Price Investment Management, Inc. filed its quarterly 13F-HR report for the period ending June 30, 2026, disclosing holdings in 738 securities with a total market value of approximately $152.6 billion. The filing shows significant positions in major technology and healthcare companies, including NVIDIA, Apple, Broadcom, and Danaher, as well as notable stakes in smaller growth-oriented firms. The report reflects the firm's diversified investment strategy across sectors, with no specific performance metrics or changes disclosed in this filing.

• · The filing reports 738 holdings with a total market value of approximately $152.6 billion.
• · The largest disclosed positions include NVIDIA (16.9M shares), Apple (7.5M shares), Broadcom (7.8M shares), and Danaher (6.9M shares).
• · The report is filed for the period ending June 30, 2026, and was submitted on August 14, 2026.
• · The filing is signed by Ellen York, Vice President.

14-08-2026

Executive Vice President Juchno Stacy M. sold 3,354 $5 Par Common Stock at $255.84 (~$858K). Juchno Stacy M. holds 18,800 shares after the transaction.

• · Executive Vice President Juchno Stacy M. sold 3,354 $5 Par Common Stock at $255.84 (~$858K)

14-08-2026

Lazard Asset Management LLC disclosed a 13.1% beneficial ownership stake in Morgan Stanley China A Share Fund, Inc. (CAF) as of June 30, 2026, holding 1,743,598 shares. The filing was made under Rule 13d-1(b) and certifies the shares were acquired in the ordinary course of business without intent to change or influence control of the issuer.

• · Filing date: August 14, 2026
• · As of date: June 30, 2026
• · Sole voting power: 1,743,598 shares
• · Shared voting power: 0 shares
• · Sole dispositive power: 1,743,598 shares
• · Shared dispositive power: 0 shares
• · Filer is an investment adviser (IA) under Section 13(d)

14-08-2026

Wells Fargo & Company filed its quarterly 13F-HR holdings report for the period ended June 30, 2026, disclosing an overall portfolio value of approximately $617.4 billion across 18,984 positions. The filing covers holdings managed by multiple subsidiaries, including Wells Fargo Clearing Services, Wells Fargo Bank N.A., and Wells Fargo Securities, LLC, and lists positions in equities, options, ETFs, and fixed income securities.

• · Report filed under SEC Form 13F-HR with accession number 0000072971-26-000304.
• · The period of report is June 30, 2026; filed as of August 14, 2026.
• · Wells Fargo's subsidiaries hold a combined portfolio of 18,984 distinct securities.
• · Top holdings disclosed include large positions in Abbott Laboratories, AbbVie Inc, and Accenture PLC.
• · Aberdeen ETFs and trusts also represent significant holdings, including over 8.4 million shares of the Aberdeen Bloomberg All Commodity K1 ETF held by Wells Fargo Bank N.A.

14-08-2026

Bank of America Corp filed its quarterly Form 13F-HR with the SEC for the period ending June 30, 2026, disclosing its institutional holdings as of that date. The report covers over 18,000 positions managed across multiple subsidiaries including Merrill Lynch, BofA Securities, and U.S. Trust, with total reported holdings exceeding $1.55 trillion. The filing provides a detailed snapshot of the firm's equity portfolio but does not include any period-over-period comparisons or performance metrics.

• · The filing includes 8 separate reporting managers, with the largest being BANK OF AMERICA NA (manager number 1) and MERRILL LYNCH, PIERCE, FENNER & SMITH INC. (manager number 2).
• · Top disclosed holdings include ABBVIE INC (over $2.5 billion across all managers), ABBOTT LABORATORIES (over $1.5 billion), and 3M CO (over $700 million).
• · The report was signed by Andres Ortiz as Authorized Signatory on August 14, 2026.

14-08-2026

Karpus Management, Inc. filed a Schedule 13G with the SEC on August 14, 2026, disclosing beneficial ownership of 477,621 common shares of Morgan Stanley India Investment Fund, Inc. (IIF), representing 5.09% of the outstanding shares. The shares are held in accounts managed by Karpus, a registered investment adviser controlled by City of London Investment Group plc, though informational barriers prevent attribution of beneficial ownership between the two entities.

• · Karpus Management, Inc. is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940.
• · Karpus is controlled by City of London Investment Group plc, which is listed on the London Stock Exchange.
• · Effective informational barriers exist between Karpus and CLIG, so voting and investment power is exercised independently by Karpus.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

14-08-2026

Japan Post Holdings Co., Ltd. and related entities filed a Schedule 13G/A disclosing beneficial ownership of 50,885,690 shares of Aflac Inc. common stock, representing 10.15% of the 501,343,298 shares outstanding as of July 28, 2026. The shares are held directly by J&A Alliance Holdings Corporation as trustee of the J&A Alliance Trust, with Japan Post as sole settlor and beneficiary. The filing is a passive investment disclosure under Rule 13d-1(c) and certifies no intent to change or influence control of Aflac.

• · The filing is an amendment (Schedule 13G/A) filed on August 14, 2026, with an event date of August 12, 2026.
• · Each of General Incorporated Association J&A Alliance, Kenji Sano, Tetsuya Numaguchi, and Japan Post Holdings disclaims beneficial ownership of the reported securities.
• · The shares are held by J&A Alliance Holdings Corporation as trustee of the J&A Alliance Trust.
• · Japan Post Holdings is the sole settlor and beneficiary of the Trust.
• · The filing certifies that the securities were not acquired with the purpose or effect of changing or influencing control of Aflac.

14-08-2026

The filing is an 8-K for Morgan Stanley Bank of America Merrill Lynch Trust 2026-C36, reporting Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) with no specific material event, financial data, or operational metrics disclosed. The filing is informational in nature, with no quantitative data, guidance, or scheduled events provided, resulting in a neutral investment signal.

14-08-2026

This filing is a tender offer by Morgan Stanley Private Markets & Alternatives Fund-Balanced, dated August 14, 2026. The document is a standard SEC filing with no specific financial details, deal structure, or strategic rationale disclosed. The analysis is limited due to the lack of quantitative data and specific transaction terms.

14-08-2026

14-08-2026

JPMorgan Private Markets Fund announced an issuer tender offer to repurchase up to approximately 5.00% of its net assets as of June 30, 2026, valued at $1,955,908,867.37. Shareholders may tender Class S, Class D, or Class I shares by September 14, 2026, with repurchases priced at the net asset value as of September 30, 2026. A 2.00% early repurchase fee applies to shares held less than 12 months, and up to 5% of proceeds may be held back pending the annual audit, expected by May 2027.

• · The offer is not conditioned on any minimum amount of shares being tendered.
• · Shareholders may withdraw tenders until the Notice Due Date (September 14, 2026) and also after October 12, 2026 if shares have not been accepted.
• · The Fund may cancel, amend, or postpone the offer at any time before the Notice Due Date.
• · There is no established trading market for the shares; transfers are strictly limited.
• · The Fund's fiscal year ends March 31, 2027; audit completion expected by end of May 2027.

14-08-2026

Charles Schwab Investment Management Inc filed its quarterly 13F-HR report for the period ending June 30, 2026, disclosing its institutional holdings. The filing lists a vast portfolio of equity positions, with major holdings including Alphabet Inc., Amazon.com Inc., AbbVie Inc., and Abbott Laboratories. The report indicates a diversified investment strategy across various sectors, with significant positions in technology and healthcare.

• · The filing is a 13F-HR for the quarter ended June 30, 2026, filed on August 14, 2026.
• · The report includes 4,441 positions with a total market value of $751,324,855,440 (approximately $751.3 billion).
• · The largest holdings by market value are Alphabet Inc. (Class A and C combined ~$26.2B), Amazon.com Inc. (~$15.7B), and Abbott Laboratories (~$5.4B).
• · The filing is a combination report, indicating that certain holdings are managed by other investment managers (e.g., American Century Companies, Ariel Investments, Baillie Gifford Overseas, Causeway Capital Management, Columbia Management Investment Advisers, JPMorgan Chase & Co).

14-08-2026